Mereo BioPharma Group (MREO) EPS (Weighted Average and Diluted): 2023-2025
Historic EPS (Weighted Average and Diluted) for Mereo BioPharma Group (MREO) over the last 3 years, with Sep 2025 value amounting to -$0.01.
- Mereo BioPharma Group's EPS (Weighted Average and Diluted) rose 50.00% to -$0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.06, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of -$0.06 for FY2024, which is 50.00% down from last year.
- As of Q3 2025, Mereo BioPharma Group's EPS (Weighted Average and Diluted) stood at -$0.01, which was up 50.00% from -$0.02 recorded in Q2 2025.
- Over the past 5 years, Mereo BioPharma Group's EPS (Weighted Average and Diluted) peaked at -$0.01 during Q4 2024, and registered a low of -$0.02 during Q1 2023.
- In the last 3 years, Mereo BioPharma Group's EPS (Weighted Average and Diluted) had a median value of -$0.02 in 2023 and averaged -$0.01.
- Examining YoY changes over the last 5 years, Mereo BioPharma Group's EPS (Weighted Average and Diluted) showed a top increase of 50.00% in 2024 and a maximum decrease of 100.00% in 2024.
- Over the past 3 years, Mereo BioPharma Group's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.01 in 2023, then increased by 0.00% to -$0.01 in 2024, then spiked by 50.00% to -$0.01 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.01 for Q3 2025, versus -$0.02 for Q2 2025 and -$0.02 for Q1 2025.